Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Investing Activities: 2011-2025

Historic Cash from Investing Activities for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to -$80,000.

  • Sonoma Pharmaceuticals' Cash from Investing Activities rose 14.07% to -$116,000 in Q1 2013 from the same period last year, while for Mar 2013 it was -$370,000, marking a year-over-year decrease of 2.78%. This contributed to the annual value of -$80,000 for FY2025, which is 3900.00% down from last year.
  • According to the latest figures from FY2025, Sonoma Pharmaceuticals' Cash from Investing Activities is -$80,000, which was down 3,900.00% from -$2,000 recorded in FY2024.
  • Over the past 5 years, Sonoma Pharmaceuticals' Cash from Investing Activities peaked at $388,000 during FY2021, and registered a low of -$258,000 during FY2023.
  • Its 3-year average for Cash from Investing Activities is -$113,333, with a median of -$80,000 in 2025.
  • As far as peak fluctuations go, Sonoma Pharmaceuticals' Cash from Investing Activities surged by 99.22% in 2024, and later crashed by 3,900.00% in 2025.
  • Over the past 5 years, Sonoma Pharmaceuticals' Cash from Investing Activities (MRY) stood at $388,000 in 2021, then tumbled by 125.52% to -$99,000 in 2022, then tumbled by 160.61% to -$258,000 in 2023, then skyrocketed by 99.22% to -$2,000 in 2024, then tumbled by 3,900.00% to -$80,000 in 2025.
  • Its Cash from Investing Activities stands at -$80,000 for FY2025, versus -$2,000 for FY2024 and -$258,000 for FY2023.